CAS: 1133819-87-0
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Azemiglitazone REF: TM-T4639CAS: 1133819-87-0 | 99.6% | 56.00 €~1,112.00 € | Mon 13 May 24 |
 | MSDC 0602 REF: TR-M755420CAS: 1133819-87-0 | - - - | 135.00 €~502.00 € | Tue 18 Jun 24 |
 | MSDC-0602 REF: 3D-IVB81987CAS: 1133819-87-0 | Min. 95% | To inquire | Mon 17 Jun 24 |
 | MSDC 0602 REF: AN-AG00IMP7CAS: 1133819-87-0 | 95% | 798.00 €~1,685.00 € | Mon 06 May 24 |
Azemiglitazone
CAS:1133819-87-0
Azemiglitazone (MSDC 0602) is an insulin sensitizer potentially for the treatment of diabetes.
Formula:
C19H17NO5S
Purity:
99.6%
Color and Shape:
Solid
Molecular weight:
371.41
Ref: TM-T4639
| 5mg | 56.00 € | |
| 10mg | 82.00 € | |
| 25mg | 156.00 € | |
| 50mg | 276.00 € | |
| 100mg | 512.00 € | |
| 500mg | 1,112.00 € | |
| 1ml*10 (DMSO) | 63.00 € |
Estimated delivery in United States, on Monday 13 May 2024
MSDC 0602
CAS:1133819-87-0
Formula:
C19H17NO5S
Color and Shape:
Pale Yellow to Light Yellow Solid
Molecular weight:
371.41
Ref: TR-M755420
| 10mg | 135.00 € | |
| 25mg | 261.00 € | |
| 50mg | 502.00 € |
Estimated delivery in United States, on Tuesday 18 Jun 2024
MSDC-0602
CAS:1133819-87-0
MSDC-0602 is a novel antidiabetic drug that has been shown to inhibit the uptake of …
Formula:
C19H17NO5S
Purity:
Min. 95%
Molecular weight:
371.41 g/mol
Ref: 3D-IVB81987
| 5mg | To inquire | |
| 10mg | To inquire | |
| 25mg | To inquire | |
| 50mg | To inquire | |
| 100mg | To inquire |
Estimated delivery in United States, on Monday 17 Jun 2024
Ref: AN-AG00IMP7
| 100mg | Discontinued | |
| 250mg | Discontinued |
